查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1504060

兽医肾臟病市场 - 全球产业规模、份额、趋势、机会和预测，按类型、动物类型、给药途径、最终用途、地区和竞争细分，2019-2029F

Veterinary Renal Disease Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Type, By Animal type, By Route of Administration, By End Use, By Region and Competition, 2019-2029F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2023 年全球兽医肾病市场估值为 160.1 亿美元，预计到 2029 年预测期内将稳定增长，复合年增长率为 5.08%。肾臟健康问题。以肾臟功能障碍为特征的肾臟疾病给包括狗、猫和牲畜在内的各种物种带来了重大的健康挑战。兽医肾病解决方案市场由多种因素驱动，包括由于人口老化、遗传倾向和饮食因素等因素导致伴侣动物肾臟病率不断增加。此外，宠物主人对肾臟健康重要性的认识不断提高，以及对先进兽医护理的需求不断增长，进一步推动了市场的成长。诊断工具在早期发现肾臟疾病、促进及时介入和管理方面发挥着至关重要的作用。市场上有大量的诊断方式，从常规血液和尿液检测到超音波和核磁共振等先进成像技术。兽医肾臟病的治疗选择范围广泛，包括饮食管理、药物介入和严重病例的外科手术。透过控制蛋白质、磷和其他营养水平来控制特定肾臟疾病的肾臟饮食正在受到兽医和宠物主人的关注。

市场概况
预测期 2025-2029
2023 年市场规模 160.1亿美元
2029 年市场规模 213.4亿美元
2024-2029 年复合年增长率 5.08%
成长最快的细分市场 诊断
最大的市场 北美洲

此外，製药公司继续创新和开发针对肾臟疾病机制的药物，以改善治疗结果并提高受影响动物的生活品质。此外，肾臟移植和微创手术等外科技术的进步为仅靠医疗管理可能不够的情况提供了可行的选择。市场也见证了对研究和开发的大量投资，旨在了解动物肾臟疾病的潜在病理生理学并确定新的治疗标靶。学术机构、兽医诊所和製药公司之间的合作推动了这一领域的创新。

然而，治疗成本高、某些地区获得先进兽医护理的机会有限以及与兽药开发和批准相关的监管障碍等挑战对市场扩张构成了限制。儘管存在这些挑战，在诊断技术、治疗方式的不断进步以及人们对动物肾臟健康重要性的认识不断提高的推动下，全球兽医肾病市场仍将稳定增长，确保未来的光明前景。

主要市场驱动因素

伴侣动物肾臟疾病盛行率上升

宠物主人的意识不断增强

对高级兽医护理的需求不断增长

主要市场挑战

治疗费用高

获得高级兽医护理的机会有限

药物开发和审批中的监管障碍

主要市场趋势

诊断技术的进步

越来越多地采用肾臟饮食和营养疗法

细分市场洞察

类型洞察

动物类型见解

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：客户之声

第 5 章：全球兽医肾臟病市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型（诊断、治疗）
    • 依动物类型（犬科动物、猫科动物、马科动物、牛科动物、其他）
    • 依给药途径（口服、注射）
    • 依最终用途（兽医院和诊所、宠物专卖店、电子商务、其他）
    • 按地区
    • 按公司划分 (2023)
  • 市场地图

第 6 章：亚太地区兽医肾臟病市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 依动物类型
    • 依给药途径
    • 按最终用途
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 澳洲
    • 日本
    • 韩国

第 7 章：欧洲兽医肾病市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 依动物类型
    • 依给药途径
    • 按最终用途
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 西班牙
    • 义大利
    • 英国

第 8 章：北美兽医肾臟病市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 依动物类型
    • 依给药途径
    • 按最终用途
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第 9 章：南美洲兽医肾臟病市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 依动物类型
    • 依给药途径
    • 按最终用途
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲兽医肾臟病市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 依动物类型
    • 依给药途径
    • 按最终用途
    • 按国家/地区
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 埃及

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 最近的发展
  • 产品发布（如有）
  • 併购（如有）

第 13 章：全球兽医肾臟病市场：SWOT 分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • Zoetis Inc.
  • Mars Inc.
  • Nestle Purina PetCare
  • Hill's Pet Nutrition, Inc.

第 15 章：5 JM Smucker 公司

  • 通用磨坊公司
  • 默克公司
  • 伊兰科动物保健公司
  • 菲布罗动物保健公司
  • 塞瓦圣动物

第 16 章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 23951

Global Veterinary Renal Disease Market was valued at USD 16.01 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.08% through 2029. The Global Veterinary Renal Disease Market encompasses a complex landscape of products, services, and research aimed at addressing renal health issues in animals. Renal disease, characterized by dysfunction of the kidneys, poses significant health challenges across various species, including dogs, cats, and livestock. The market for veterinary renal disease solutions is driven by several factors, including the increasing prevalence of renal disorders in companion animals due to factors such as aging populations, genetic predispositions, and dietary factors. Moreover, the rise in awareness among pet owners regarding the importance of renal health and the growing demand for advanced veterinary care further propel market growth. Diagnostic tools play a crucial role in identifying renal diseases early, facilitating timely intervention and management. The market witnesses a plethora of diagnostic modalities ranging from routine blood and urine tests to advanced imaging techniques like ultrasound and MRI. Treatment options for veterinary renal disease span a wide spectrum, including dietary management, pharmaceutical interventions, and surgical procedures in severe cases. Renal diets formulated to manage specific renal conditions by controlling protein, phosphorus, and other nutrient levels are gaining traction among veterinarians and pet owners alike.

Market Overview
Forecast Period2025-2029
Market Size 2023USD 16.01 Billion
Market Size 2029USD 21.34 Billion
CAGR 2024-20295.08%
Fastest Growing SegmentDiagnosis
Largest MarketNorth America

Additionally, pharmaceutical companies continue to innovate and develop drugs targeting renal disease mechanisms to improve treatment outcomes and enhance the quality of life for affected animals. Also, advancements in surgical techniques, such as kidney transplantation and minimally invasive procedures, offer viable options for cases where medical management alone may be insufficient. The market is also witnessing significant investment in research and development aimed at understanding the underlying pathophysiology of renal diseases in animals and identifying novel therapeutic targets. Collaborations between academic institutions, veterinary clinics, and pharmaceutical companies drive innovation in this field.

However, challenges such as high treatment costs, limited accessibility to advanced veterinary care in certain regions, and regulatory hurdles associated with the development and approval of veterinary drugs pose constraints to market expansion. Despite these challenges, the Global Veterinary Renal Disease Market is poised for steady growth driven by ongoing advancements in diagnostic technologies, treatment modalities, and increasing awareness about the importance of renal health in animals, ensuring a promising outlook for the future.

Key Market Drivers

Rising Prevalence of Renal Disorders in Companion Animals

The rising prevalence of renal disorders in companion animals is a significant driver fueling the growth of the Global Veterinary Renal Disease Market. Companion animals, including dogs and cats, are increasingly susceptible to renal dysfunction due to various factors, including aging populations, genetic predispositions, and dietary habits. As pets live longer lives, thanks to advancements in veterinary care and nutrition, they become more prone to age-related conditions, such as renal disorders.

One of the primary contributing factors to the increasing prevalence of renal disorders in companion animals is the aging pet population. Just like humans, animals experience age-related changes in their organs, including the kidneys. As pets grow older, the likelihood of developing renal dysfunction increases, leading to a higher prevalence of renal diseases within this demographic.

The genetic predispositions play a significant role in certain breeds being more susceptible to renal disorders. For example, certain dog breeds, such as the Cavalier King Charles Spaniel and the Bull Terrier, are genetically predisposed to conditions like chronic kidney disease (CKD) and renal dysplasia. Similarly, in cats, breeds like the Maine Coon and the Siamese are more prone to renal issues. These genetic predispositions contribute to the overall prevalence of renal disorders in companion animals.

Dietary habits also play a crucial role in the rising prevalence of renal disorders among pets. Poor-quality diets high in phosphorus, sodium, and protein can strain the kidneys over time, leading to renal dysfunction. Additionally, inadequate hydration levels can further exacerbate the risk of developing renal diseases. As pet owners become more aware of the importance of nutrition in maintaining overall health, there's a growing demand for specialized renal diets formulated to support kidney function and mitigate the progression of renal disorders.

The increasing prevalence of renal disorders in companion animals translates to a higher demand for veterinary services, diagnostic tests, and treatment options aimed at managing these conditions effectively. Veterinarians are seeing more cases of renal dysfunction in their practice and are equipped with a wide array of diagnostic tools and treatment modalities to address the needs of their patients. This surge in demand for veterinary renal care contributes significantly to the growth of the Global Veterinary Renal Disease Market, creating opportunities for innovation and advancement in the field of veterinary medicine.

Growing Awareness Among Pet Owners

Growing awareness among pet owners regarding the importance of renal health in animals is a significant driver boosting the Global Veterinary Renal Disease Market. Pet owners are increasingly recognizing the impact of renal disorders on the overall well-being and longevity of their beloved animal companions, leading to heightened vigilance and proactive measures to safeguard their pets' renal health.

As pet ownership continues to rise globally, so does the level of awareness and concern among pet owners about their pets' health. Pet owners are increasingly educated about various health issues, including renal diseases, through various channels such as veterinary clinics, pet care websites, social media, and pet-related publications. This increased awareness prompts pet owners to be more vigilant about monitoring their pets' health and seeking timely veterinary care when needed.

Likewise, advances in communication technologies have facilitated the dissemination of information about pet health and wellness. Pet owners now have easy access to a wealth of information about renal diseases, including risk factors, symptoms, preventive measures, and treatment options. This accessibility to information empowers pet owners to make informed decisions regarding their pets' healthcare needs, including routine screenings for renal health and adopting renal-friendly dietary practices.

The growing awareness among pet owners is also driven by the efforts of veterinarians and animal health professionals to educate pet owners about renal diseases and their management. Veterinary clinics often provide educational resources, conduct awareness campaigns, and offer preventive healthcare services tailored to renal health. These initiatives aim to engage pet owners in proactive measures to prevent, detect, and manage renal disorders in their pets, thereby fostering a collaborative approach to pet healthcare.

Moreover, the emotional bond between pet owners and their pets fuels the desire to ensure the best possible quality of life for their furry companions. Pet owners are increasingly invested in maintaining their pets' health and well-being, including renal health, as part of their commitment to providing optimal care and companionship. This emotional connection drives pet owners to prioritize preventive healthcare measures and seek prompt veterinary intervention when their pets show signs of renal dysfunction.

Growing Demand for Advanced Veterinary Care

The growing demand for advanced veterinary care is a key factor contributing to the expansion of the Global Veterinary Renal Disease Market. Pet owners are increasingly seeking sophisticated medical interventions and specialized services to ensure the health and well-being of their beloved animal companions. This rising demand for advanced veterinary care extends to the diagnosis, treatment, and management of renal diseases in animals.

One of the primary drivers of the growing demand for advanced veterinary care is the evolving human-animal bond. Pets are increasingly regarded as integral members of the family, and pet owners are willing to invest in their pets' health and happiness. As a result, pet owners are increasingly seeking comprehensive veterinary care that goes beyond routine vaccinations and preventive measures to include advanced diagnostics, specialized treatments, and personalized care plans tailored to their pets' individual needs.

Advancements in veterinary medicine and technology have expanded the scope of veterinary care, offering pet owners access to a wide range of innovative diagnostic tools and treatment modalities for managing renal diseases in animals. From advanced imaging techniques such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) to minimally invasive surgical procedures and cutting-edge pharmaceutical interventions, veterinarians have an array of options at their disposal to diagnose, treat, and manage renal disorders effectively.

Moreover, the increasing prevalence of renal diseases in companion animals has fueled the demand for specialized veterinary services focused on renal health. Veterinary clinics and hospitals are investing in state-of-the-art facilities, equipment, and expertise to meet the growing needs of pet owners seeking advanced renal care for their pets. These specialized services encompass comprehensive renal health assessments, personalized treatment plans, nutritional counseling, and ongoing monitoring to optimize renal function and improve patient outcomes.

Additionally, the rise in pet insurance coverage and pet healthcare financing options has made advanced veterinary care more accessible and affordable for pet owners. As pet owners become more aware of the benefits of early detection and intervention in managing renal diseases, they are increasingly willing to invest in advanced veterinary care to ensure the best possible quality of life for their pets.

Key Market Challenges

High Treatment Costs

One of the primary challenges hindering the Global Veterinary Renal Disease Market is the high cost associated with the diagnosis and treatment of renal disorders in animals. Advanced diagnostic tests, such as ultrasound, MRI, and CT scans, can be expensive, making them inaccessible to some pet owners. Additionally, specialized treatments, including renal diets, pharmaceutical interventions, and surgical procedures, can incur significant expenses, particularly for chronic conditions requiring long-term management.

The high treatment costs pose a barrier to access to advanced veterinary care, especially for pet owners with limited financial resources. As a result, some pet owners may opt for conservative management or delay seeking veterinary care altogether, leading to suboptimal outcomes for their pets. Addressing the affordability of veterinary renal care is essential to ensure equitable access to treatment options for all pet owners and mitigate the impact of high treatment costs on market growth.

Limited Accessibility to Advanced Veterinary Care

Another challenge facing the Global Veterinary Renal Disease Market is the limited accessibility to advanced veterinary care in certain regions, particularly in rural and underserved areas. Veterinary clinics equipped with specialized diagnostic tools and expertise in renal care may be concentrated in urban centers, leaving pet owners in remote areas with limited access to essential veterinary services.

The lack of accessibility to advanced veterinary care exacerbates disparities in healthcare access among pet owners, resulting in delayed diagnosis, inadequate treatment, and poor clinical outcomes for animals with renal disorders. Bridging the gap in accessibility to veterinary renal care requires strategic investments in veterinary infrastructure, telemedicine initiatives, and mobile veterinary services to extend the reach of specialized care to underserved communities.

Regulatory Hurdles in Drug Development and Approval

Regulatory hurdles associated with the development and approval of veterinary drugs pose significant challenges to innovation in the Global Veterinary Renal Disease Market. Unlike human medicine, where regulatory pathways for drug approval are well-established, veterinary drug development faces unique challenges, including limited market incentives, regulatory requirements, and ethical considerations.

The process of obtaining regulatory approval for veterinary drugs can be lengthy, complex, and costly, leading to a dearth of approved pharmaceutical options for the treatment of renal disorders in animals. Moreover, the regulatory landscape for veterinary drugs varies across different regions, further complicating the drug development process and impeding market entry for potential therapies.

Key Market Trends

Advancements in Diagnostic Technologies

Advancements in diagnostic technologies are playing a pivotal role in boosting the Global Veterinary Renal Disease Market, revolutionizing the way renal disorders are diagnosed and managed in animals. These technological innovations have significantly enhanced the accuracy, efficiency, and accessibility of renal disease diagnosis, enabling veterinarians to provide timely intervention and personalized treatment strategies for affected animals.

One of the key advancements in diagnostic technologies is the availability of sophisticated imaging modalities such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI). These imaging techniques offer detailed visualization of the kidneys and surrounding structures, allowing veterinarians to identify structural abnormalities, tumors, cysts, and other renal lesions with greater precision. Additionally, advanced imaging technologies facilitate the early detection of renal diseases and provide valuable insights into disease progression, guiding treatment decisions and optimizing patient outcomes.

Also, laboratory diagnostics have witnessed significant advancements, with the development of novel biomarkers and specialized tests for the evaluation of renal function and disease. Routine blood and urine tests, including serum creatinine, blood urea nitrogen (BUN), urine protein-to-creatinine ratio (UPC), and urine specific gravity, provide valuable information about renal function and help in the diagnosis and monitoring of renal disorders. Additionally, emerging biomarkers such as symmetric dimethylarginine (SDMA) offer improved sensitivity and specificity for the early detection of renal dysfunction, enabling veterinarians to initiate appropriate interventions at the earliest stages of disease.

Moreover, point-of-care testing (POCT) devices have revolutionized renal disease diagnosis by enabling rapid and on-site assessment of renal function parameters. These portable devices allow veterinarians to perform real-time diagnostic tests in the clinic or field setting, facilitating immediate decision-making and timely intervention for animals with renal disorders. POCT devices for renal function assessment, such as handheld refractometers, dipstick tests, and portable ultrasound machines, provide convenient and cost-effective solutions for screening, diagnosis, and monitoring of renal diseases in animals.

Rising Adoption of Renal Diets and Nutritional Therapies

The rising adoption of renal diets and nutritional therapies is significantly boosting the Global Veterinary Renal Disease Market, as pet owners and veterinarians increasingly recognize the critical role of nutrition in managing renal disorders in animals. Renal diseases, characterized by impaired kidney function, require careful dietary management to alleviate symptoms, slow disease progression, and improve overall quality of life for affected animals. As a result, there's a growing demand for specialized renal diets and nutritional therapies tailored to support kidney health and mitigate the progression of renal dysfunction.

Renal diets are specially formulated to meet the unique nutritional needs of animals with renal disorders, with specific emphasis on controlling protein, phosphorus, sodium, and other nutrient levels. These diets are designed to reduce the workload on the kidneys, minimize the accumulation of waste products, and maintain electrolyte balance, thereby preserving renal function and delaying the onset of complications associated with renal disease. Renal diets may also include additional ingredients such as omega-3 fatty acids, antioxidants, and potassium citrate to provide further support for renal health and overall well-being.

The adoption of renal diets and nutritional therapies is driven by the growing awareness among pet owners and veterinarians about the importance of nutrition in managing renal diseases. Pet owners are increasingly educated about the role of diet in maintaining optimal health and are willing to invest in specialized dietary interventions to ensure the well-being of their animal companions. Likewise, veterinarians recognize the benefits of incorporating nutritional management into the overall treatment plan for animals with renal disorders, leveraging the therapeutic potential of renal diets to improve clinical outcomes and enhance patient care.

Also, advancements in pet food technology and manufacturing processes have led to the development of high-quality renal diets that are palatable, digestible, and nutritionally balanced. These diets come in various forms, including dry kibble, wet food, and prescription formulations, catering to the diverse preferences and dietary needs of pets with renal disease. Additionally, nutritional supplements and dietary additives targeting specific aspects of renal function, such as phosphate binders and potassium supplements, offer complementary therapeutic options for managing renal disorders in animals.

Segmental Insights

Type Insights

In 2023, the Veterinary Renal Disease Market witnessed a notable dominance in the Diagnosis segment. Renal diseases in animals require precise identification for effective treatment, driving the demand for advanced diagnostic tools and techniques. Veterinarians increasingly relied on diagnostics to accurately assess renal health, detect abnormalities, and monitor disease progression. Diagnostic methods such as ultrasound, blood tests, urine analysis, and imaging techniques like CT scans played pivotal roles in diagnosing renal conditions in diverse animal species. Additionally, advancements in diagnostic technologies facilitated quicker and more accurate diagnoses, enhancing treatment outcomes.

While treatment options are crucial in managing renal diseases, the emphasis on early and accurate diagnosis underscored the significance of the Diagnosis segment in driving market growth. Timely identification of renal issues allowed veterinarians to intervene promptly, potentially mitigating disease progression and improving the quality of life for afflicted animals.

Animal Type Insights

Based on the animal type, feline segment emerged as the dominant segment in the global veterinary renal disease market in 2023. Feline renal disease is relatively common among domestic cats, with studies indicating a high incidence of chronic kidney disease (CKD) in older cats. As cats age, they are more prone to developing renal dysfunction, making them susceptible to renal diseases such as CKD. The aging feline population, coupled with improved veterinary care that prolongs cats' lifespan, has led to an increased prevalence of renal diseases in cats worldwide.

Regional Insights

North America emerged as the dominant region in the global veterinary renal disease market in 2023, holding the largest market share. North America boasts a well-developed veterinary healthcare infrastructure with advanced diagnostic facilities, specialized veterinary clinics, and a highly skilled workforce. The region's robust veterinary care ecosystem enables timely diagnosis, effective treatment, and comprehensive management of renal diseases in animals, driving demand for renal care solutions. Pet ownership rates in North America are among the highest globally, with a significant portion of households owning companion animals such as dogs and cats. The strong bond between pet owners and their animals fosters a culture of preventive healthcare and proactive management of pet health issues, including renal diseases. As a result, there's a substantial market for veterinary renal care products and services in the region.

Key Market Players

Zoetis Inc

Nestle Purina PetCare

Mars Inc.

Hill's Pet Nutrition, Inc.

The J.M. Smucker Company

General Mills Inc.

Merck & Co., Inc

Elanco Animal Health Inc.

Phibro Animal Health Corporation

Ceva Sante Animale

Report Scope:

In this report, the Global Veterinary Renal Disease Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Renal Disease Market, By Type:

    Diagnosis Treatment

Veterinary Renal Disease Market, By Animal Type:

    Canine Feline Equine Bovine Others

Veterinary Renal Disease Market, By Route of Administration:

    Oral Injectable

Veterinary Renal Disease Market, By End Use:

    Veterinary Hospitals & Clinics Pet Speciality Stores E-commerce Others

Veterinary Renal Disease Market, By Region:

    North America
    • United States
    • Canada
    • Mexico
    Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
    Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    South America
    • Brazil
    • Argentina
    • Colombia
    Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Renal Disease Market.

Available Customizations:

Global Veterinary Renal Disease Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Renal Disease Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Diagnosis, Treatment)
    • 5.2.2. By Animal type (Canine, Feline, Equine, Bovine, Others)
    • 5.2.3. By Route of Administration (Oral, Injectable)
    • 5.2.4. By End Use (Veterinary Hospitals & Clinics, Pet Specialty Stores, E-commerce, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2023)
  • 5.3. Market Map

6. Asia Pacific Veterinary Renal Disease Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Animal type
    • 6.2.3. By Route of Administration
    • 6.2.4. By End Use
    • 6.2.5. By Country
  • 6.3. Asia Pacific: Country Analysis
    • 6.3.1. China Veterinary Renal Disease Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Animal type
        • 6.3.1.2.3. By Route of Administration
        • 6.3.1.2.4. By End Use
    • 6.3.2. India Veterinary Renal Disease Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Animal type
        • 6.3.2.2.3. By Route of Administration
        • 6.3.2.2.4. By End Use
    • 6.3.3. Australia Veterinary Renal Disease Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Animal type
        • 6.3.3.2.3. By Route of Administration
        • 6.3.3.2.4. By End Use
    • 6.3.4. Japan Veterinary Renal Disease Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type
        • 6.3.4.2.2. By Animal type
        • 6.3.4.2.3. By Route of Administration
        • 6.3.4.2.4. By End Use
    • 6.3.5. South Korea Veterinary Renal Disease Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type
        • 6.3.5.2.2. By Animal type
        • 6.3.5.2.3. By Route of Administration
        • 6.3.5.2.4. By End Use

7. Europe Veterinary Renal Disease Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Animal type
    • 7.2.3. By Route of Administration
    • 7.2.4. By End Use
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Veterinary Renal Disease Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Animal type
        • 7.3.1.2.3. By Route of Administration
        • 7.3.1.2.4. By End Use
    • 7.3.2. Germany Veterinary Renal Disease Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Animal type
        • 7.3.2.2.3. By Route of Administration
        • 7.3.2.2.4. By End Use
    • 7.3.3. Spain Veterinary Renal Disease Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Animal type
        • 7.3.3.2.3. By Route of Administration
        • 7.3.3.2.4. By End Use
    • 7.3.4. Italy Veterinary Renal Disease Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Animal type
        • 7.3.4.2.3. By Route of Administration
        • 7.3.4.2.4. By End Use
    • 7.3.5. United Kingdom Veterinary Renal Disease Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Animal type
        • 7.3.5.2.3. By Route of Administration
        • 7.3.5.2.4. By End Use

8. North America Veterinary Renal Disease Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Animal type
    • 8.2.3. By Route of Administration
    • 8.2.4. By End Use
    • 8.2.5. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Veterinary Renal Disease Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Animal type
        • 8.3.1.2.3. By Route of Administration
        • 8.3.1.2.4. By End Use
    • 8.3.2. Mexico Veterinary Renal Disease Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Animal type
        • 8.3.2.2.3. By Route of Administration
        • 8.3.2.2.4. By End Use
    • 8.3.3. Canada Veterinary Renal Disease Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Animal Type
        • 8.3.3.2.3. By Route of Administration
        • 8.3.3.2.4. By End Use

9. South America Veterinary Renal Disease Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Animal type
    • 9.2.3. By Route of Administration
    • 9.2.4. By End Use
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Veterinary Renal Disease Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Animal type
        • 9.3.1.2.3. By Route of Administration
        • 9.3.1.2.4. By End Use
    • 9.3.2. Argentina Veterinary Renal Disease Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Animal type
        • 9.3.2.2.3. By Route of Administration
        • 9.3.2.2.4. By End Use
    • 9.3.3. Colombia Veterinary Renal Disease Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Animal type
        • 9.3.3.2.3. By Route of Administration
        • 9.3.3.2.4. By End Use

10. Middle East and Africa Veterinary Renal Disease Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Animal type
    • 10.2.3. By Route of Administration
    • 10.2.4. By End Use
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Veterinary Renal Disease Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Animal type
        • 10.3.1.2.3. By Route of Administration
        • 10.3.1.2.4. By End Use
    • 10.3.2. Saudi Arabia Veterinary Renal Disease Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Animal type
        • 10.3.2.2.3. By Route of Administration
        • 10.3.2.2.4. By End Use
    • 10.3.3. UAE Veterinary Renal Disease Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Animal type
        • 10.3.3.2.3. By Route of Administration
        • 10.3.3.2.4. By End Use
    • 10.3.4. Egypt Veterinary Renal Disease Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type
        • 10.3.4.2.2. By Animal type
        • 10.3.4.2.3. By Route of Administration
        • 10.3.4.2.4. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches (If Any)
  • 12.3. Mergers & Acquisitions (If Any)

13. Global Veterinary Renal Disease Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Zoetis Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (In case of listed)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Mars Inc.
  • 15.3. Nestle Purina PetCare
  • 15.4. Hill's Pet Nutrition, Inc.
  • 15.5. The J.M. Smucker Company
  • 15.6. General Mills Inc.
  • 15.7. Merck & Co., Inc.
  • 15.8. Elanco Animal Health Inc.
  • 15.9. Phibro Animal Health Corporation
  • 15.10. Ceva Sante Animale

16. Strategic Recommendations

17. About Us & Disclaimer